SCHEDULE OF INITIAL PUBLIC OFFERING PROCEEDS TO COMMON STOCK SUBJECT TO POSSIBLE REDEMPTION (Details) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2023	Mar. 31, 2023	Jun. 30, 2023
Subsidiary, Sale of Stock [Line Items]
Total			$ 73,305,000
Cash to the operating account			657,285
Underwriting expenses			1,725,000
Other offering expenses			263,675
Amount held back for Sponsor portion of risk capital in event of full exercise of the over-allotment			279,040
Total			2,925,000
Balance	$ 71,221,220	$ 70,380,000	70,380,000
Accretion for common stock subject to redemption amount	834,681	841,220
Balance	$ 72,055,901	$ 71,221,220	72,055,901
I P O Including Over Allotment [Member]
Subsidiary, Sale of Stock [Line Items]
Total			69,000,000
Private Placement [Member]
Subsidiary, Sale of Stock [Line Items]
Total			$ 4,305,000